Journal profile · ENDOCRINOLOGY & METABOLISM
Diabetology & Metabolic Syndrome
ISSN 1758-5996 · BioMed Central · BRAZIL · Founded 2009
Diabetology & Metabolic Syndrome: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 4.87; fully open access; APC about USD 2,990; median 89 days to acceptance (111 articles, last 24 months); community-reported acceptance: about 37.5%; 503 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Diabetology & Metabolic Syndrome is published by BioMed Central and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Diabetes, Cardiovascular Risks, and Lipoproteins, Diabetes Treatment and Management and Diabetes Management and Research, together about 33% of its articles. Its main subfields are Endocrinology, Diabetes and Metabolism. (generated from OpenAlex topic counts and CAS ranking data)
Diabetology & Metabolic Syndrome publishes articles on all aspects of the pathophysiology of diabetes and metabolic syndrome. By publishing original material exploring any area of laboratory, animal or clinical research into diabetes and metabolic syndrome, the journal offers a highly visible forum for new insights and discussions into the issues of importance to the relevant community. The journal aims to help health care providers improve the management of people afflicted by these syndromes by increasing knowledge and stimulating research in the field. Diabetology & Metabolic Syndrome reports on basic research and clinical studies in the areas of genetics, pathophysiology, immunology, epidemiology, clinical management, therapeutic strategies, education, nutrition and psychosocial research relevant for the study of diabetes and metabolic syndrome.
From the journal's Aims & Scope
Research area (LetPub): ENDOCRINOLOGY & METABOLISM
Editor-in-chief Marcello CasacciaPublisher website
Editorial board by country: 6 in mainland China (about 9%); most named Brazil 17, United States 8, India 7, Mainland China 6, Italy 6 (67 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Diabetes, Cardiovascular Risks, and LipoproteinsMedicine15.5%
- Diabetes Treatment and ManagementMedicine9.4%
- Diabetes Management and ResearchMedicine8%
- Adipokines, Inflammation, and Metabolic DiseasesMedicine7.1%
- Hyperglycemia and glycemic control in critically ill and hospitalized patientsMedicine5.2%
- Diabetes and associated disordersBiochemistry, Genetics and Molecular Biology4.7%
- Chronic Kidney Disease and DiabetesMedicine4.5%
- Diabetes Management and EducationMedicine3.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Endocrinology & Metabolism | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Endocrinology & Metabolism | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Endocrinology & Metabolism | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
EmbaseCASPublisher website
Other: Google Scholar, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.87LetPub ·
- Impact factor (publisher) 2025
- 4.9Publisher website ·
- 5-year impact factor (publisher) 2025
- 4.9Publisher website ·
- CiteScore 2026-06
- 5.9LetPub ·
- SJR 2026-06
- 1.25LetPub ·
- SNIP 2026-06
- 1.17LetPub ·
- h-index
- 38LetPub ·
- h-index
- 100OpenAlex ·
- i10-index
- 1,424OpenAlex ·
- 2-year mean citedness
- 5.28OpenAlex ·
- Self-citation rate
- 4.1%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 491LetPub ·
- Downloads per year (publisher) 2025
- 2,600,000Publisher website ·
Articles by year OpenAlex count · 2,959 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 240 | 240 | 87 |
| 2025 | 503 | 503 | 2,502 |
| 2024 | 315 | 315 | 2,996 |
| 2023 | 261 | 261 | 4,227 |
| 2022 | 198 | 198 | 3,741 |
| 2021 | 152 | 152 | 3,903 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
89 daysMedian, submission to acceptance · P25–P75 66 days – 149 days
- Acceptance to online
- median 15 days (111 articles)
- Submission to online
- median 119 days
- Sample
- 111 articles with submission and acceptance dates (819 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 7.5 monthsLetPub ·
- Average acceptance (community reports)
- 37.5%LetPub ·
- Submission to first decision
- 5 daysPublisher website ·
- Submission to publication (journal-reported)
- about 16 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 2,590 / USD 2,990 / GBP 2,290 | Yes | CC BY, CC BY-NC-ND | |
| OpenAlex | USD 2,890 / EUR 2,490 / GBP 2,190 | — | — | |
| LetPub | GBP 2,090 / USD 2,790 / EUR 2,390 | Yes | — | |
| Publisher website | GBP 2,290 / USD 2,990 / EUR 2,590 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers2, by deadline
Publisher websiteWhat to prepare1 items from the author guidelines
- Suggested reviewers
- Optional
Article types accepted5
- brief reportResearch Comment Correspondence Review Brief ReportLength not stated
- commentResearch Comment Correspondence Review Brief ReportLength not stated
- correspondenceResearch Comment Correspondence Review Brief ReportLength not stated
- researchResearch Comment Correspondence Review Brief ReportLength not stated
- reviewResearch Comment Correspondence Review Brief ReportLength not stated
Policy excerpts from the journal's websiteData availability, License & copyright, Open access, Peer review
- Data availability Formatting the 'Availability of data and materials' section of your manuscript
The following format for the 'Availability of data and materials section of your manuscript should be used:
Source ↗Publisher website ·- License & copyright Licensing and copyright
Open access under CC BY-NC-ND or CC BY licence; authors retain copyright. Model summary
Creative Commons licences Open access articles in Springer Nature journals are published under Creative Commons licences. These provide an industry-standard framework to support easy re-use of open access material. Under Creative Commons licences, authors retain copyright of their articles. Diabetology & Metabolic Syndrome articles are published open access under a CC BY-NC-ND (Creative Commons At…
Source ↗Publisher website ·- Open access Benefits of open access
Publishing open access (OA) offers a number of benefits, including greater reach and readership for your work: Cited more 1.6x more citations of OA articles than non-OA articles across all subjects Downloaded more 4x more downloads of OA articles than non-OA articles Greater impact 2.5x more Altmetric attention. OA articles attracted 1.9x more news mentions and 1.2x more policy mentions Open acces…
Source ↗Publisher website ·- Peer review Peer review policy
Peer review is the process used to evaluate the quality of a manuscript before publication. Independent researchers in the relevant field assess submitted manuscripts to check their validity and robustness. Their feedback guides editors in making publication decisions. Typically, two or more experts evaluate each manuscript based on three main criteria: scientific robustness: is the research metho…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- BioMed Central
- Country or region
- BRAZIL
- Language
- English
- Founded
- 2009
- ISSN
- 1758-5996
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Diabetology & Metabolic Syndrome
What CAS zone is Diabetology & Metabolic Syndrome in?
In the 2025 upgraded edition of the CAS Journal Ranking, Diabetology & Metabolic Syndrome is in Zone 3 of Medicine, and in Zone 3 of the minor category Endocrinology & Metabolism. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Diabetology & Metabolic Syndrome?
The latest impact factor listed by LetPub is 4.87; CiteScore 5.9, h-index 100.
How long does peer review take at Diabetology & Metabolic Syndrome?
Based on the dates recorded on 111 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 89 days (interquartile range 66–149 days); authors report an average review time of about 7.5 months; the community-reported acceptance is “about 37.5%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Diabetology & Metabolic Syndrome based?
Of the 67 board members whose country the journal's board page names, 6 (about 9%) are in mainland China; the countries named most often are Brazil (17), United States (8) and India (7). Counted from the institutions listed on the board page; for reference only.
Which databases index Diabetology & Metabolic Syndrome?
According to LetPub and DOAJ records, Diabetology & Metabolic Syndrome is indexed in SCIE, Scopus and DOAJ. The journal's website also lists Embase and CAS; that list has not been checked against each database.
Is Diabetology & Metabolic Syndrome open access, and what is the APC?
Diabetology & Metabolic Syndrome is a fully open-access journal. APC about USD 2,990.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .